Literature DB >> 28190890

C-Peptide, Baseline and Postprandial Insulin Resistance after a Carbohydrate-Rich Test Meal - Evidence for an Increased Insulin Clearance in PCOS Patients?

J Stassek1, J Erdmann2, F Ohnolz1, F D Berg3, M Kiechle1, V Seifert-Klauss1.   

Abstract

Introduction Known characteristics of patients with PCOS include infertility, menstrual disorders, hirsutism and also often insulin resistance. These symptoms increase with increasing body weight. In the LIPCOS study (Lifestyle Intervention for Patients with Polycystic Ovary Syndrome [PCOS]) long-term changes of the PCOS in dependence on pregnancy and parenthood were systematically assessed. In the framework of the LIPCOS study, PCOS patients were given a standardised carbohydrate-rich test meal in order to examine glucose homeostasis and insulin secretion. The results were compared with those of a eumenorrhoeic control group who all had corresponding BMI values and corresponding ages. Methods and Patients 41 PCOS patients (without diabetes) and 68 controls received a standardised carbohydrate-rich test meal (260 kcal, 62 % carbohydrates, 32 % fat, 6 % proteins) in order to generate a submaximal insulin and glucose stimulation. The values were determined at baseline and postprandial after 60, 120 and 180 minutes. In addition, the corresponding C-peptide levels were recorded. Results In the PCOS patients (n = 41), the insulin secretion test after a standardised test meal showed almost identical baseline and postprandial insulin levels when compared with those of the age- and BMI-matched eumenorrhoeic controls (n = 68). In the PCOS patients, the baseline and postprandial glucose levels were significantly elevated (92.88 ± 10.28 [PCOS] vs. 85.07 ± 9.42 mg/dL [controls]; p < 0.001) so was C-peptide (p < 0.025). Conclusions In the present study we have shown for the first time that, after consumption of a standardised test meal, PCOS patients formally exhibit a higher fasting insulin resistance than controls. In spite of the higher stimulated C-peptide levels, the insulin levels did not increase more strongly with increasing glucose levels than in controls which may be indicative of a higher insulin clearance in PCOS patients.

Entities:  

Keywords:  C-peptide; impaired glucose tolerance; insulin; polycystic ovarian syndrome

Year:  2017        PMID: 28190890      PMCID: PMC5292905          DOI: 10.1055/s-0042-119199

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  31 in total

1.  A randomized trial comparing the effect of weight loss and exercise training on insulin sensitivity and glucose metabolism in coronary artery disease.

Authors:  Lene Rørholm Pedersen; Rasmus Huan Olsen; Anders Jürs; Christian Anholm; Mogens Fenger; Steen Bendix Haugaard; Eva Prescott
Journal:  Metabolism       Date:  2015-07-17       Impact factor: 8.694

2.  Studies on human proinsulin. Isolation and amino acid sequence of the human pancreatic C-peptide.

Authors:  P E Oyer; S Cho; J D Peterson; D F Steiner
Journal:  J Biol Chem       Date:  1971-03-10       Impact factor: 5.157

3.  Serum immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (non-insulin-dependent) diabetic patients and control subjects.

Authors:  V Mohan; P S Sharp; H R Cloke; J M Burrin; B Schumer; E M Kohner
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

4.  Do Pregnancy and Parenthood Affect the Course of PCO Syndrome? Initial Results from the LIPCOS Study (Lifestyle Intervention for Patients with Polycystic Ovary Syndrome [PCOS]).

Authors:  J Stassek; F Ohnolz; Y Hanusch; M Schmidmayr; D Berg; M Kiechle; V R Seifert-Klauss
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-11       Impact factor: 2.915

Review 5.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

6.  [Serum C-peptide concentration in overweight and obese women with polycystic ovary syndrome].

Authors:  Marzena Maciejewska-Jeske; Arleta Szczesna; Blazej Męczekalski
Journal:  Pol Merkur Lekarski       Date:  2010-08

7.  Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).

Authors:  Elizabeth L M Barr; Paul Z Zimmet; Timothy A Welborn; Damien Jolley; Dianna J Magliano; David W Dunstan; Adrian J Cameron; Terry Dwyer; Hugh R Taylor; Andrew M Tonkin; Tien Y Wong; John McNeil; Jonathan E Shaw
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

8.  Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.

Authors:  Enrico Carmina; Rogerio A Lobo
Journal:  Fertil Steril       Date:  2004-09       Impact factor: 7.329

Review 9.  Follicle dynamics and anovulation in polycystic ovary syndrome.

Authors:  Stephen Franks; Jaroslav Stark; Kate Hardy
Journal:  Hum Reprod Update       Date:  2008-05-22       Impact factor: 15.610

10.  Development of hyperinsulinemia and insulin resistance during the early stage of weight gain.

Authors:  Johannes Erdmann; Bianca Kallabis; Ulrich Oppel; Oleg Sypchenko; Stefan Wagenpfeil; Volker Schusdziarra
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-01-02       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.